Manuel Román

Effect of the Most Relevant CYP3A4 and CYP3A5 Polymorphisms on the Pharmacokinetic Parameters of 10 CYP3A Substrates

Miriam Saiz‐Rodríguez, Susana Almenara, Marcos Navares‐Gómez et al. · Biomedicines · 2020 · 110 citations · Full text

Influence of <i><scp>CYP</scp>2D6</i>,<i><scp>CYP</scp>3A4</i>,<i><scp>CYP</scp>3A5</i> and <i><scp>ABCB</scp>1</i> Polymorphisms on Pharmacokinetics and Safety of Aripiprazole in Healthy Volunteers

Carmen Belmonte, Dolores Ochoa, Manuel Román et al. · Basic & Clinical Pharmacology & Toxicology · 2018 · 79 citations · Full text

Histone modifications associated with biological drug response in moderate‐to‐severe psoriasis

María C. Ovejero‐Benito, Alejandra Reolid, Patricia Sánchez‐Jiménez et al. · Experimental Dermatology · 2018 · 74 citations

The relationship between tumour necrosis factor (TNF)-α promoter and<i>IL12B</i>/<i>IL-23R</i>genes polymorphisms and the efficacy of anti-TNF-α therapy in psoriasis: a case-control study

Enrique Vázquez Gallo, Teresa Cabaleiro, Manuel Román et al. · British Journal of Dermatology · 2013 · 73 citations

Effects of CYP2D6 Genotype on the Pharmacokinetics, Pharmacodynamics, and Safety of Risperidone in Healthy Volunteers

Jesús Novalbos, Rosario López‐Rodríguez, Manuel Román et al. · Journal of Clinical Psychopharmacology · 2010 · 68 citations

Cyp2d6 Genotypes, Cyp2d6 Genotype, Healthy Volunteers +11